Volume 19, Number 8—August 2013
Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: July 24, 2013; Expiration date: July 24, 2014
Upon completion of this activity, participants will be able to:
• Describe the epidemiology and most common settings of infection of norovirus outbreaks in general
• Analyze the epidemiology and clinical presentation of the GII.4 Sydney norovirus infection.
Carol E. Snarey, MA, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Carol E. Snarey, MA, has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Eyal Leshem, MD; Mary Wikswo, MPH; Leslie Barclay; Eric Brandt; William Storm, MPH; Ellen Salehi, MPH; Traci DeSalvo, MPH; Tim Davis; Amy Saupe; Ginette Dobbins; Hillary Booth; Christianne Biggs, MS; Katie Garman, MPH; Amy Woron, PhD; Umesh Parashar, MBBS; Jan Vinjé, PhD; and Aron Hall, DVM, have disclosed no relevant financial relationships.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: July 23, 2013
- Page last updated: July 23, 2013
- Page last reviewed: July 23, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)